Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

TRI-LO-MARZIA TABLET

norgestimate and ethinyl estradiol
$0.1102per EA

Manufacturer

Lupin Pharmaceuticals Inc.

NDC

68180083773

Classification

Generic

Dosage Form

KIT

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA200541

On Market Since

1/8/2020

Price History

1W

0.0%

1M

-0.6%

3M

-2.2%

6M

-1.4%

1Y

-4.1%

3Y

-25.7%

5Y

-35.5%

All

-47.7%

Generic Alternatives

7 alternatives • Same active ingredient

TRI-LO-ESTARYLLA TABLET
Generic
70700012085•Xiromed LLC
$0.1102
MILI 0.25-0.035 MG TABLET
Generic
65862077685•Aurobindo Pharma Limited
$0.1260
+14% more
VYLIBRA 28 TABLET
Generic
50102023513•Afaxys Pharma, LLC
$0.1260
+14% more
MONO-LINYAH 28 TABLET
Generic
16714036004•NorthStar Rx LLC
$0.1260
+14% more
FEMYNOR 28 TABLET
Generic
69238155106•Amneal Pharmaceuticals NY LLC
$0.1278
+16% more
NYMYO 0.25-0.035 MG (28) TAB
Generic
51862064506•Mayne Pharma
$0.1293
+17% more
TRI-SPRINTEC TABLET
Generic
00555901858•Teva Pharmaceuticals USA Inc.
$0.1332
+21% more

Related Drugs

Same classification

No related drugs found.

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy